Dentists in Valders, WI Accepting Medicare
3 Dentists found. Showing 1 - 3
 Dr. Thomas Peirick, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 519 Christel Dr, Valders, WI 54245 Phone: 920-775-4531 Fax: 920-775-4180 |
 Dr. Laura Guevara, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 519 Christel Drive, Valders, WI 54245 Phone: 920-775-4531 Fax: 920-775-4180 |
Dr. Thomas John Peterson, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 519 Christel Dr., Valders, WI 54245 Phone: 920-775-4531 Fax: 920-775-4180 |
News Archive
Increased cholesterol levels can affect microenvironment of bone marrow
Increased cholesterol levels are being increasingly recognised as risk factors for the onset and progression of several cancers. Now researchers in Portugal show that high levels of cholesterol can affect the microenvironment of the bone marrow, so that more cells move from the bone marrow to peripheral, circulating blood.
Glutamine could help obese people reduce inflammation of fat tissue
Glutamine could help people with obesity reduce inflammation of fat tissue and reduce fat mass, according to a new study at Karolinska Institutet in Sweden and the University of Oxford in the U.K. The researchers also show how glutamine levels can alter gene expression in several different cell types.
Zika virus found to specifically kill glioblastoma brain cancer cells
According to a latest study supported by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, the deadly Zika virus could be used to kill a specific type of brain cancer cells and sparing the neighbouring healthy brain cells. Although experimental in stage, this finding has wide implications for those suffering from these cancers.
Spectrum Pharmaceuticals to be traded on NASDAQ Global Select Market
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that effective January 3, 2011, it will begin trading on the NASDAQ Global Select Market. The NASDAQ Global Select Market is the highest NASDAQ listing tier based on financial and liquidity criteria. Prior to the effectiveness of this change in the New Year, shares of Spectrum Pharmaceuticals will continue to be traded on the NASDAQ Global Market.
Research shows cellular component may play vital role in how lung cancer spreads
A cellular component known as the Golgi apparatus may play a role in how lung cancer metastasizes, according to researchers at The University of Texas MD Anderson Cancer Center whose findings were reported in the Nov. 21 online issue of the Journal of Clinical Investigation.
› Verified 2 days ago